Effect of carbapenem restriction on prescribing trends for immunocompromised wards at an academic medical center.
Academic Medical Centers
Anti-Bacterial Agents
/ administration & dosage
Antimicrobial Stewardship
Bacterial Infections
/ drug therapy
Drug Resistance, Multiple, Bacterial
Drug Utilization
Guideline Adherence
Hospitals
Humans
Immunocompromised Host
Interrupted Time Series Analysis
Meropenem
/ administration & dosage
Practice Patterns, Physicians'
Antimicrobial stewardship
Bone marrow transplant
Formulary restriction and preauthorization
Hematology-oncology
Immunocompromised patients
Journal
American journal of infection control
ISSN: 1527-3296
Titre abrégé: Am J Infect Control
Pays: United States
ID NLM: 8004854
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
21
11
2018
revised:
31
12
2018
accepted:
31
12
2018
pubmed:
9
2
2019
medline:
9
6
2020
entrez:
9
2
2019
Statut:
ppublish
Résumé
The recently described proportion of carbapenem consumption metric was used to assess the effectiveness of formulary restriction for carbapenems for 2 units housing predominantly immunocompromised patients at a large academic medical center. Interrupted time series analysis revealed a significant decrease in meropenem use for hematology-oncology and bone marrow transplant units after restriction.
Identifiants
pubmed: 30732979
pii: S0196-6553(19)30003-3
doi: 10.1016/j.ajic.2018.12.027
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Meropenem
FV9J3JU8B1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1035-1037Informations de copyright
Copyright © 2019 Association for Professionals in Infection Control and Epidemiology, Inc. All rights reserved.